Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.56 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | TGM2 | P21980 | 11/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL177994 | 0.98 | ZDHHC20 (0.58) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL29161807 | 0.96 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL11694993 | 0.96 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL27760620 | 0.96 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL4807878 | 0.96 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL5050870 | 0.96 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL462110 | 0.96 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL9625870 | 0.96 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL11695495 | 0.96 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR | |
| SCHEMBL177827 | 0.96 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2EPHX2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697912-B2 | N-(1-hydroxyethyl) carboxamide compound and process for producing same | SHOWA DENKO K.K. (JP) | 2014-04-15 | — | — | US | disclosed |
| US-8383745-B2 | Method for producing N-methyl-N-vinylacetamide having improved stability and polymerizability | SHOWA DENKO K.K. (JP) | 2013-02-26 | — | — | US | disclosed |
| US-20110294974-A1 | N-(1-HYDROXYETHYL ) CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME | SHOWA DENKO K.K. (JP) | 2011-12-01 | — | — | US | disclosed |
| US-20100280204-A1 | METHOD FOR PRODUCING N-METHYL-N-VINYLACETAMIDE HAVING IMPROVED STABILITY AND POLYMERIZABILITY | SHOWA DENKO K.K. (JP) | 2010-11-04 | — | — | US | disclosed |
| EP-2239250-A1 | METHOD FOR PRODUCING N-METHYL-N-VINYLACETAMIDE HAVING IMPROVED STABILITY AND POLYMERIZABILITY | Showa Denko K.K. (JP) | 2010-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294974-A1 | N-(1-HYDROXYETHYL ) CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME | ADH1A, ADH1C, CNKSR1 | ZDHHC20 2180/4885ZDHHC2 1414/4885EPHX2 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.